Phyto Extractions Inc

PINK:XTXXF USA Drug Manufacturers - Specialty & Generic
Market Cap
$211.57K
Market Cap Rank
#39351 Global
#12819 in USA
Share Price
$0.04
Change (1 day)
+0.00%
52-Week Range
$0.04 - $0.04
All Time High
$11.69
About

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand. It also provides consulting and white label manufacturing. The company was formerly knowns as Phyto Extractions Inc. and changed its name to Adastra Holdings Ltd. in September 2021. Adastr… Read more

Phyto Extractions Inc (XTXXF) - Total Assets

Latest total assets as of September 2025: $16.01 Million USD

Based on the latest financial reports, Phyto Extractions Inc (XTXXF) holds total assets worth $16.01 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Phyto Extractions Inc - Total Assets Trend (2018–2024)

This chart illustrates how Phyto Extractions Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Phyto Extractions Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Phyto Extractions Inc's total assets of $16.01 Million consist of 53.3% current assets and 46.7% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 6.7%
Accounts Receivable $2.94 Million 15.2%
Inventory $5.59 Million 28.9%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $4.21K 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2018–2024)

This chart illustrates how Phyto Extractions Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Phyto Extractions Inc's current assets represent 53.3% of total assets in 2024, an increase from 38.4% in 2018.
  • Cash Position: Cash and equivalents constituted 6.7% of total assets in 2024, down from 37.8% in 2018.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
  • Asset Diversification: The largest asset category is inventory at 28.9% of total assets.

Phyto Extractions Inc Competitors by Total Assets

Key competitors of Phyto Extractions Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Phyto Extractions Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.18 - 1.28

Strong asset utilization - Phyto Extractions Inc generates 1.28x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -68.43% - -9.56%

Negative ROA - Phyto Extractions Inc is currently not profitable relative to its asset base.

Phyto Extractions Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.38 0.61 1.03
Quick Ratio 0.16 0.32 0.63
Cash Ratio 0.00 0.00 0.00
Working Capital $-10.47 Million $ -6.59 Million $ 105.09K

Phyto Extractions Inc - Advanced Valuation Insights

This section examines the relationship between Phyto Extractions Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.13
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -40.2%
Total Assets $19.34 Million
Market Capitalization $208.88K USD

Valuation Analysis

Below Book Valuation: The market values Phyto Extractions Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Phyto Extractions Inc's assets decreased by 40.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Phyto Extractions Inc (2018–2024)

The table below shows the annual total assets of Phyto Extractions Inc from 2018 to 2024.

Year Total Assets Change
2024-12-31 $19.34 Million -40.20%
2023-12-31 $32.34 Million +1.69%
2022-12-31 $31.80 Million +10.60%
2021-12-31 $28.76 Million +109.33%
2020-12-31 $13.74 Million +21.02%
2019-12-31 $11.35 Million +81.48%
2018-12-31 $6.25 Million --